2020年に56件の介入研究を対象に行われたこのレビューは「障害や発達の成果に影響を与えているというエビデンスはない」と結論しているがどうなんだろう?? https://t.co/GJj7cJYzps
Most recent @cochranecollab meta-analyses, including changes in conclusions over time. https://t.co/1cpONA9vNW https://t.co/mR4saSmRdK
@MyNutritionSci Perhaps the most powerful evidence, is the prevention of death and necrotising enterocolitis in preterm babies with probiotics. For me this is a kind of definitive proof that in some specific situations microbiota can play a major role htt
RT @GMFHx: According to @cochranecollab probiotics have been proposed to reduce the risk of necrotising enterocolitis and mortality in very…
According to @cochranecollab probiotics have been proposed to reduce the risk of necrotising enterocolitis and mortality in very preterm infants: https://t.co/P2tddmWoUC But when choosing the right probiotic keep in mind that strain matters: https://t.co/
RT @EBNEO: Links to topics we cover in the episode: 1. Tweet that inspired this journal club: https://t.co/2WO3jQXucp 2. The Cochrane rev…
Links to topics we cover in the episode: 1. Tweet that inspired this journal club: https://t.co/2WO3jQXucp 2. The Cochrane review: https://t.co/KFA5KdMfYQ 3. More about GRADE: https://t.co/ZVtzpTxy2n 4. Study by Hay et al. (h/t @JohnZupancic): https://
RT @EBNEO: Inspired by Friday’s #ebneoalerts highlighting an updated SR/MA from @CochraneNeonate:
@NECUK_Charity @drpaulclarke Cochrane view is different... https://t.co/nxGVC3yvtM
@HuntKatieA @EBNEO Not convincing.... https://t.co/nxGVC3yvtM
RT @EBNEO: Updated SRMA from @CochraneNeonate on probiotic use in VLBW infants summaries evidence from over 10,000 infants across 56 random…
RT @EBNEO: Updated SRMA from @CochraneNeonate on probiotic use in VLBW infants summaries evidence from over 10,000 infants across 56 random…
RT @EBNEO: Updated SRMA from @CochraneNeonate on probiotic use in VLBW infants summaries evidence from over 10,000 infants across 56 random…
RT @EBNEO: Inspired by Friday’s #ebneoalerts highlighting an updated SR/MA from @CochraneNeonate:
RT @EBNEO: Inspired by Friday’s #ebneoalerts highlighting an updated SR/MA from @CochraneNeonate:
RT @EBNEO: Updated SRMA from @CochraneNeonate on probiotic use in VLBW infants summaries evidence from over 10,000 infants across 56 random…
Inspired by Friday’s #ebneoalerts highlighting an updated SR/MA from @CochraneNeonate:
RT @EBNEO: Updated SRMA from @CochraneNeonate on probiotic use in VLBW infants summaries evidence from over 10,000 infants across 56 random…
Se necesitan más estudios. Prontos a iniciar RCT multicéntrico de probióticos en Chile.
RT @EBNEO: Updated SRMA from @CochraneNeonate on probiotic use in VLBW infants summaries evidence from over 10,000 infants across 56 random…
RT @EBNEO: Updated SRMA from @CochraneNeonate on probiotic use in VLBW infants summaries evidence from over 10,000 infants across 56 random…
RT @EBNEO: Updated SRMA from @CochraneNeonate on probiotic use in VLBW infants summaries evidence from over 10,000 infants across 56 random…
@NursesGroup
RT @EBNEO: Updated SRMA from @CochraneNeonate on probiotic use in VLBW infants summaries evidence from over 10,000 infants across 56 random…
Updated SRMA from @CochraneNeonate on probiotic use in VLBW infants summaries evidence from over 10,000 infants across 56 randomized controlled trials. Authors suggest more large high quality trials are needed. #EBNEOalerts #neoEBM https://t.co/Tpntk6wsrn
RT @DrAbdulRazak_MD: How would large RCTs improve evidence’s certainty when prior study limitations will continue to affect evidence Unle…
How would large RCTs improve evidence’s certainty when prior study limitations will continue to affect evidence Unless they rely on evidence from sensitivity analysis of high-quality RCTs in future MA If so, the current Ss analysis is not informative?